Almost immediately after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) virus emerged, it was evident that people with chronic diseases, including diabetes, were …

SARS-CoV-2 was the first pathogen implied in a worldwide health emergency in the last
decade. Containment measures have been adopted by various countries to try to stop …

The SARS-CoV-2 pandemic has had an unprecedented effect on global health, mortality
and healthcare provision. Diabetes has emerged as a key disease entity over the pandemic …

Tuberculosis (TB) is a major cause of ill health worldwide. Until the coronavirus (COVID-19)
pandemic, TB was the leading cause of death from a single infectious agent. COVID-19 has …

Introduction Semaglutide, the only glucagon-like peptide-1 receptor agonist (GLP-1 RA)
available in subcutaneous and oral formulation for treatment of type 2 diabetes (T2D), has …

The COVID-19 pandemic has resulted in significant alterations to and implications for the
lives of millions of people, and especially for those with pre-existing medical conditions. The …

Introduction The COVID-19 pandemic significantly disrupted primary healthcare globally,
with particular impacts on diabetes and hypertension care. This review will examine the …

Introduction Glycemic effects of COVID-19 lockdowns on patients with type 2 diabetes (T2D)
are controversial. In this long-term observation, we aimed (1) to analyze changes in HbA1c …

Background The effect directly from the coronavirus disease 2019 (COVID-19) infection on
health and fatality has received considerable attention, particularly among people with type …

Patients affected by COVID-19 are prone to facing disorders in multiple systems and organs,
which can lead to deleterious diseases; in addition, people with pre-existing diseases may …